Estonia
Thyrocare Technologies Ltd (BOM:539871) Q1 2025 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Expansions
Revenue: INR 144 crores standalone and INR 157 crores consolidated, 16% year-on-year growth at consolidated levels.Gross Margin: Standalone gross margin at 70%